News | January 06, 2009

Medrad Sponsors PET Study at University of Zurich

January 6, 2009 - MEDRAD has agreed to collaborate with the University of Zurich in a study on dynamic PET imaging with the MEDRAD Intego PET Infusion System, in which researchers will utilize MEDRAD’s system for controlling the radioactive dose delivered during PET imaging procedures.

The study will examine patients with tumors in the chest or abdomen and compare standard quantitative techniques, such as standard uptake value (SUV), with more advanced kinetic and compartmental models. One of the primary goals of the research is to explore how controlled delivery technology can enable dynamic imaging by providing additional clinical utility and making these advanced techniques more practical. By enabling the benefit of repeatable infusion of the prescribed FDG dose to all subjects in the study, the Intego System is a key element in the research.

“The research will explore the clinical viability of dynamic imaging with PET,” said Alfred Buck, M.D., University of Zurich (Switzerland). The University of Zurich is a leading institution in dynamic PET research, and has licensed its proprietary FDG delivery technology to MEDRAD for use in the Intego PET Infusion System.

The Intego System is designed to automatically extract a patient dose from a multi-dose vial and delivers it directly to the patient, virtually eliminating manual dose preparation and handling, and the corresponding radiation exposure to the technologist inherent in manual preparation. With the Intego System’s dose-on-demand capability, the prescribed dose can be delivered when the patient and clinician are ready. This should enable the clinician to respond to schedule changes, patient delays and add-on patients.

The system’s features include real-time dose availability information, an integrated ionization chamber and an optional weight-based dose calculation, that allow the healthcare provider to more precisely customize each patient’s dose. Safety features include a tungsten multi-dose vial shield, a fully lead-lined mobile cart, and an automated saline flush to remove residual FDG from the line after each infusion.

For more information: www.medrad.com

Related Content

OptiStar Elite injector
Feature | Contrast Media Injectors | March 07, 2018 | Grand View Research Inc.
The global contrast media injectors market is expected to reach $1.4 billion by 2025, growing at a compound annual...
TriHealth in Cincinnati

TriHealth in Cincinnati.

Sponsored Content | Case Study | Contrast Media Injectors | March 06, 2018
The continuing search for advantages to improve workflow has radiology departments constantly searching for new...
Guerbet Presents Contrast&Care Injection Management Solution at ECR 2018
News | Contrast Media | February 28, 2018
February 28, 2018 — Guerbet will present its new Contrast&Care application, as well as other...
Guerbet to Participate in French Interventional Radiology Conference
News | Contrast Media | October 10, 2017
Guerbet announced it will be taking part in the 65th edition of the Journées Francophones de Radiologie (JFR) that will...
ACR Offers Revised Contrast Media in Imaging Manual
News | Contrast Media | July 17, 2017
The American College of Radiology (ACR) recently revised its authoritative guide for the safe and effective use of...
Sponsored Content | Case Study | Contrast Media Injectors | April 13, 2017
The volume of computed tomography (CT) imaging exams continues to grow in the United States,[2] adding pressure to...
contrast media
Feature | Contrast Media Injectors | March 02, 2017 | By Jeff Zagoudis
With medical imaging use on the rise, contrast media use is expected to grow as well, according to a May 2016 report...
contrast media
News | Contrast Media | December 09, 2016
At the 2016 Annual Meeting of the Radiological Society of North America (RSNA 2016), Bracco Diagnostics Inc. showcased...
GlobalData, contrast media injectors market,
News | Contrast Media Injectors | May 03, 2016
The global market for contrast media injectors is set to increase from $830 million in 2015 to almost $1.8 billion by...
CTA, CT, contrast media injector, contrast injector, EmpowerCTA

Bracco's new EmpowerCTA+, designed for cardiac CT angiography exams.

Feature | Contrast Media Injectors | April 29, 2016 | Jeff Zagoudis
The biggest trend in contrast media injector technology today is one seen throughout all of healthcare — doing more...
Overlay Init